4//SEC Filing
RESPONSE BIOMEDICAL CORP 4
Accession 0001437749-16-028520
CIK 0000806888operating
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 8:57 PM ET
Size
7.0 KB
Accession
0001437749-16-028520
Insider Transaction Report
Form 4
Wang Jonathan Jian
Director
Transactions
- Award
Common Stock
2016-03-24+26,176→ 71,396 total - Award
Stock Option (right to buy)
2016-03-24+5,000→ 5,000 totalExercise: $0.85Exp: 2026-03-23→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the earlier of three (3) years after the effective date or two (2) years following the reporting person's termination date. The reporting person has elected to defer receipt of the common stock underlying the restricted share units until a later date not to exceed the expiration date.
- [F2]Exercise prices shown are denominated in Canadian dollars.
- [F3]Subject to the reporting person's continued service as a director of the company through each vesting date, 100% of the shares subject to the option shall vest and become exercisable on March 24, 2017.
Documents
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000806888
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 8:57 PM ET
- Size
- 7.0 KB